Lijun Shen
-
- Liver Disease and Transplantation 3
- Hepatocellular Carcinoma Treatment and Prognosis 2
-
- SARS-CoV-2 and COVID-19 Research 2
- COVID-19 Clinical Research Studies 2
-
- Liver Disease Diagnosis and Treatment 4
-
- RNA Interference and Gene Delivery 2
-
- Blood Pressure and Hypertension Studies 2
-
- Organ Transplantation Techniques and Outcomes 2
- Co-authors
- Lei XingHu‐Lin JiangMei HuJingfeng BiQing ZhouYiran AnLijun SunHuahao Fan
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Lijun Shen
16 papers receiving 329 citations
Peers
Comparison fields: 5 of 78
- Hepatology 45
- Infectious Diseases 61
- Cancer Research 46
- Modeling and Simulation 14
- Biomaterials 39
Countries citing papers authored by Lijun Shen
This map shows the geographic impact of Lijun Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijun Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijun Shen more than expected).
Fields of papers citing papers by Lijun Shen
This network shows the impact of papers produced by Lijun Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijun Shen. The network helps show where Lijun Shen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lijun Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 0 | |
| 3 | 2023 | 3 | |
| 4 | 2022 | 4 | |
| 5 | 2021 | 17 | |
| 6 | Factors affecting recurrent positive RT-PCR results in clinically cured COVID-19 patients: a multicenter study. | 2021 | 2 |
| 7 | 2020 | 64 | |
| 8 | 2020 | 29 | |
| 9 | 2020 | 1 | |
| 10 | 2020 | 8 | |
| 11 | 2019 | 52 | |
| 12 | 2019 | 1 | |
| 13 | 2018 | 90 | |
| 14 | 2017 | 16 | |
| 15 | 2016 | 28 | |
| 16 | 2015 | 3 | |
| 17 | 2014 | 14 |
About Lijun Shen
Lijun Shen is a scholar working on Hepatology, Modeling and Simulation and Pharmaceutical Science, having authored 17 papers that have together received 333 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (4 papers), Liver Disease and Transplantation (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), RNA Interference and Gene Delivery (2 papers), COVID-19 Clinical Research Studies (2 papers), Blood Pressure and Hypertension Studies (2 papers) and Organ Transplantation Techniques and Outcomes (2 papers). The work is most often cited by research in Hepatology (45 citations), Infectious Diseases (61 citations) and Cancer Research (46 citations). Lijun Shen has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Lei Xing, Hu‐Lin Jiang, Mei Hu, Jingfeng Bi, Qing Zhou, Yiran An, Lijun Sun, Huahao Fan, Junfen Fan and Boan Li.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.